Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators.

iScience

Department of Pharmacology and Toxicology, Virginia Commonwealth University, 1112 E. Clay St., McGuire Hall 100D, Richmond, VA 23298, USA. Electronic address:

Published: April 2018

In the clinical setting, analgesic tolerance is a primary driver of diminished pain control and opioid dose escalations. Integral to this process are primary afferent sensory neurons, the first-order components of nociceptive sensation. Here, we characterize the factors modulating morphine action and tolerance in mouse small diameter dorsal root ganglia (DRG) neurons. We demonstrate that acute morphine inactivates tetrodotoxin-resistant (TTX-R) Na channels in these cells. Chronic exposure resulted in tolerance to this effect, which was prevented by treatment with oral vancomycin. Using colonic supernatants, we further show that mediators in the gut microenvironment of mice with chronic morphine exposure can induce tolerance and hyperexcitability in naive DRG neurons. Tolerance (but not hyperexcitability) in this paradigm was mitigated by oral vancomycin treatment. These findings collectively suggest that gastrointestinal microbiota modulate the development of morphine tolerance (but not hyperexcitability) in nociceptive primary afferent neurons, through a mechanism involving TTX-R Na channels.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993194PMC
http://dx.doi.org/10.1016/j.isci.2018.03.003DOI Listing

Publication Analysis

Top Keywords

tolerance hyperexcitability
12
dorsal root
8
root ganglia
8
primary afferent
8
drg neurons
8
ttx-r channels
8
oral vancomycin
8
tolerance
7
neurons
5
tolerance morphine-induced
4

Similar Publications

Targeting Kv7 Potassium Channels for Epilepsy.

CNS Drugs

January 2025

Division of Pharmacology, Department of Neuroscience, University of Naples "Federico II", Naples, Italy.

Voltage-gated Kv7 potassium channels, particularly Kv7.2 and Kv.7.

View Article and Find Full Text PDF

Familial adult myoclonus epilepsy (FAME) management relies on antiseizure medications (ASMs), which inadequately address myoclonus and cortical tremor. This study evaluates Perampanel (PER), an AMPA-receptor antagonist, for treating FAME symptoms. Fifteen FAME2 patients participated in an observational prospective study.

View Article and Find Full Text PDF

Mexiletine is the first choice drug in the treatment of non-dystrophic myotonias. However, 30% of patients experience little benefit from mexiletine due to poor tolerability, contraindications and limited efficacy likely based on pharmacogenetic profile. Safinamide inhibits neuronal voltage-gated sodium and calcium channels and shows anticonvulsant activity, in addition to a reversible monoamine oxidase-B inhibition.

View Article and Find Full Text PDF

Transcranial static magnetic stimulation for amyotrophic lateral sclerosis: a bicentric, randomised, double-blind placebo-controlled phase 2 trial.

Lancet Reg Health Eur

October 2024

Istituto Auxologico Italiano IRCCS, Department of Neurology and Laboratory of Neuroscience, Piazzale Brescia 20, Milano 20149, Italy.

Background: Enhanced glutamatergic transmission leading to motor neuron death is considered the major pathophysiological mechanism of amyotrophic lateral sclerosis (ALS). Motor cortex excitability can be suppressed by transcranial static magnetic stimulation (tSMS), thus tSMS can be evaluated as a potential treatment for ALS. The aim of present study was to investigate the efficacy and safety of tSMS in ALS.

View Article and Find Full Text PDF
Article Synopsis
  • Nearly half of the 39 million people living with HIV are affected by HIV-associated neurocognitive disorder (HAND), which includes symptoms ranging from cognitive impairment to dementia, and currently has no established treatment.
  • The HIV protein TAT is believed to contribute to HAND by causing neurotoxicity and resulting in network hyperexcitability that correlates with cognitive decline.
  • The study demonstrates that the antiepileptic drug levetiracetam (LEV) can alleviate excitatory synaptic transmission issues and cognitive deficits in mice expressing the TAT protein, suggesting LEV might be a potential treatment for HAND.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!